Development and Evaluation of 1'-Acetoxychavicol Acetate (ACA)-Loaded Nanostructured Lipid Carriers for Prostate Cancer Therapy.

MLA

Subramaniam, Bavani, et al. “Development and Evaluation of 1’-Acetoxychavicol Acetate (ACA)-Loaded Nanostructured Lipid Carriers for Prostate Cancer Therapy.” Pharmaceutics, vol. 13, no. 4, Mar. 2021. EBSCOhost, https://doi.org/10.3390/pharmaceutics13040439.

APA

Subramaniam, B., Arshad, N. M., Malagobadan, S., Misran, M., Nyamathulla, S., Mun, K. S., & Nagoor, N. H. (2021). Development and Evaluation of 1’-Acetoxychavicol Acetate (ACA)-Loaded Nanostructured Lipid Carriers for Prostate Cancer Therapy. Pharmaceutics, 13(4). https://doi.org/10.3390/pharmaceutics13040439

Chicago

Subramaniam, Bavani, Norhafiza M Arshad, Sharan Malagobadan, Misni Misran, Shaik Nyamathulla, Kein Seong Mun, and Noor Hasima Nagoor. 2021. “Development and Evaluation of 1’-Acetoxychavicol Acetate (ACA)-Loaded Nanostructured Lipid Carriers for Prostate Cancer Therapy.” Pharmaceutics 13 (4). doi:10.3390/pharmaceutics13040439.